Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-25

Clinical Trial Update: A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trials.gov entry describes a Phase 1/2 study of Yiyang Huoluo Decoction for coronary heart disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yiyang Huoluo Decoction (Yiyang Huoluo Decoction)

Snippet

Sponsor: Xia Liang | Conditions: Coronary Heart Disease, Coronary Artery Disease | Phase 1, Phase 2 | Status: RECRUITING